Old Web
English
Sign In
Acemap
>
Paper
>
Risankizumab in Severe Asthma: A Phase IIa, Placebo-Controlled Study
Risankizumab in Severe Asthma: A Phase IIa, Placebo-Controlled Study
2021
Christopher E. Brightling
Parameswaran Nair
David J. Cousins
Renaud Louis
Dave Singh
Keywords:
Medicine
Risankizumab
Phase (matter)
Placebo-controlled study
severe asthma
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]